Shining a Light on New Approaches for Ovarian Cancer Treatment and Detection
Researchers are helping advance ovarian cancer care with breakthroughs that are reshaping treatment and early detection approaches.
Progress Against Cancer
Researchers are helping advance ovarian cancer care with breakthroughs that are reshaping treatment and early detection approaches.
Cancer survivors profiled over the past 15 years in the AACR Cancer Progress Reports shared updates on their lives and the progress made against cancer.
Combination of targeted therapy and chemotherapy prolongs survival in lung cancer, and FDA approves a chemotherapy-releasing device to treat bladder cancer.
FDA expands selumetinib approval to include pediatric patients as young as 1 year with inoperable plexiform neurofibromas. The U.S. Food and Drug Administration (FDA) has approved selumetinib (Koselugo) granules and capsules for pediatric patients...
The FDA has approved a delivery system that, once inserted into the bladder, delivers a local dose of the drug gemcitabine. The U.S. Food and Drug Administration (FDA) has approved a gemcitabine intravesical system...
The second AACR Childhood Cancer Predisposition Workshop gathered experts from around the world to refine surveillance strategies, expanding recommendations to nearly 100 syndromes.
New research is redefining the role of surgery, revealing approaches to help cancer patients preserve their organs, function, and identity without compromising outcomes.
Rising prostate cancer rates reignite questions about screening guidelines, and a government report describing the health risks of alcohol may never be published.
New research highlights approaches that could provide better long-term quality of life for childhood cancer survivors into adulthood.
Some people’s cancer treatment may not align with their care goals, and a blood test may detect ovarian cancer at early stages.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More